Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Amortizatization of Intangibles (2022 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $26000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles rose 4.0% year-over-year to $26000.0, compared with a TTM value of -$559000.0 through Sep 2025, down 170.85%, and an annual FY2024 reading of $138000.0, up 109.09% over the prior year.
  • Amortizatization of Intangibles was $26000.0 for Q3 2025 at Fennec Pharmaceuticals, up from $25000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $723000.0 in Q1 2024 and bottomed at -$636000.0 in Q4 2024.
  • Average Amortizatization of Intangibles over 4 years is $21285.7, with a median of $19500.0 recorded in 2023.
  • Peak annual rise in Amortizatization of Intangibles hit 3515.0% in 2024, while the deepest fall reached 4340.0% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $15000.0 in 2022, then changed by 0.0% to $15000.0 in 2023, then crashed by 4340.0% to -$636000.0 in 2024, then surged by 104.09% to $26000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for FENC at $26000.0 in Q3 2025, $25000.0 in Q2 2025, and $26000.0 in Q1 2025.